KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,725 JPY | -0.71% |
|
+1.70% | +14.98% |
| 06-05 | Kyowa Kirin Repurchases 3.3 Million Shares in May | MT |
| 05-07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
ETFs positioned on Kyowa Kirin Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 14 M€ | +13.95% | ||
| 0.44% | 10 M€ | +18.29% | - | |
| 0.41% | 240 M€ | +20.84% | ||
| 0.39% | 28,050 M€ | +18.60% | - | |
| 0.36% | 62,153 M€ | +18.58% | ||
| 0.36% | 14,619 M€ | +17.61% | - | |
| 0.30% | 25 M€ | +14.44% | ||
| 0.26% | 69 M€ | +18.15% | ||
| 0.23% | 57 M€ | +21.74% | ||
| 0.20% | 0 M€ | 0.00% | - | |
| 0.17% | 4,931 M€ | +19.78% | ||
| 0.17% | 9,764 M€ | +20.03% | ||
| 0.15% | 17 M€ | +18.02% | - | |
| 0.15% | 14 M€ | +5.66% | - | |
| 0.15% | 5 M€ | +10.09% | - | |
| 0.13% | 19,753 M€ | +18.18% | - | |
| 0.13% | 138,841 M€ | +19.24% | ||
| 0.12% | 29 M€ | +8.37% | - | |
| 0.10% | 469 M€ | -2.05% | ||
| 0.10% | 3,859 M€ | +18.82% | - | |
| 0.09% | 4 M€ | -.--% | - | |
| 0.03% | 7 M€ | +0.11% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.03% | 7 M€ | +3.25% | - | |
| 0.02% | 261 M€ | -.--% | - | |
| 0.02% | 200 M€ | +13.22% | - |
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
26/06/2024
- Détachement de for dividende intermédiaire
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,725
JPY
Average target price
3,054
JPY
Spread / Average Target
+12.08%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.98% | 9.14B | |
| +7.95% | 72.21B | |
| -24.60% | 4.33B | |
| +15.26% | 4.28B | |
| +28.46% | 4.15B | |
| +7.76% | 2.19B | |
| -35.98% | 1.98B | |
| +7.76% | 1.98B | |
| -47.71% | 1.68B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
- Funds and ETFs Kyowa Kirin Co. Ltd.
